Latest filing published 15 May 2024 for Humacyte, Inc., €302k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Gordon M. Binder: trading record in brief
Gordon M. Binder is a declared insider of Humacyte, Inc., with filings sourced from SEC (Form 4). Between 1 September 2022 and 15 May 2024, the trades on record add up to 3 filings.
On the market, this insider has only ever bought: 3 purchases, €769k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2024 alone, the filings show 1 purchase and no sales.
Half of the purchases are above €273k and half below. None of the 3 purchases we analysed coincided with buying by another insider of the same company within 30 days.
The newest entry dates from 15 May 2024: an open-market purchase of €302k, in Humacyte, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Gordon M. Binder
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,000 shares@ US$6.5739.2% of flowCommon StockSEC:0001818382-24-000058:0Canonical exit: 13 Aug 2024 (T+90)
- 61,841 shares@ US$4.4035.6% of flowCommon StockSEC:0001818382-22-000119:0Canonical exit: 1 Dec 2022 (T+90)
- 48,159 shares@ US$4.0025.2% of flowCommon StockSEC:0001818382-22-000117:0Canonical exit: 30 Nov 2022 (T+90)
3 of 3 declarations